Since 2017, the HealthQuake Summit series has demonstrated that a small, invitation-only, interdisciplinary forum can successfully convene internationally recognized leaders in medicine, technology, business, policy, and research to explore the accelerating convergence of healthcare and advanced technology. Across three Summits, HealthQuake validated both the strength of its discussion format and the relevance of its core themes.

The inaugural 2017 Summit established the conceptual framework of the “HealthQuake” itself: the accelerating convergence of medicine and technology. Delegates examined regenerative medicine, artificial intelligence, robotics, digital medicine, genomic medicine, telemedicine, and globalization of healthcare, anticipating major transformations in medical practice, education, hospital systems, and healthcare economics. The Summit successfully attracted internationally prominent delegates, including Anthony Atala (Wake Forest Institute for Regenerative Medicine), Jean-Michel Dubernard (leader of the world’s first face transplant team), former U.S. Surgeon General Antonia Novello, Ford futurist Sheryl Connelly, Stryker chief scientist Chunwu Wu, and senior leaders from Tenet Health, Wayne State University, the Detroit Medical Center, and major business and policy organizations.

The 2019 Summit shifted from broad futurist framing to deeper exploration of specific disruptive technologies, particularly artificial intelligence, big data analytics, precision medicine, pathogen detection, and the bioartificial kidney. Key conclusions included the growing role of AI in diagnosis and treatment, the importance of interoperable electronic health record systems, the emergence of personalized “N of 1” medicine, and the likelihood that hospitals themselves would be fundamentally transformed by digital technologies and consumer-centered care models. The Summit highlighted work by leading innovators including Atul Butte (Chief Data Scientist, University of California), Shuvo Roy (developer of the implantable bioartificial kidney), and Charles Shanley (developer of real-time Raman spectroscopy pathogen detection systems).

The 2022 Summit further expanded the scope of HealthQuake into digital caregiving, artificial intelligence in oncology, neurotechnology, tissue engineering, cellular rejuvenation, and public-interest capitalism. Presentations demonstrated the increasing maturity of technologies previously discussed only conceptually in earlier meetings. Topics included AI-assisted oncology using IBM Watson, digital home healthcare ecosystems, brain-machine neurotechnology capable of manipulating neural ensembles, bioprinting and tissue engineering, epigenetic rejuvenation of cells, and new investment models designed to support socially beneficial healthcare innovation. Speakers included leaders from Columbia University, the University of Maryland, Turn Biotechnologies, Brazil’s Ceará Cancer Institute, and Japan’s Alliance Forum Foundation and DEFTA Partners.

Collectively, the three Summits validated several important conclusions:

• The HealthQuake concept itself — the accelerating convergence of medicine, AI, robotics, genomics, digital systems, and advanced materials — has proven both credible and increasingly urgent.
• The Summit format successfully fostered unusually candid, cross-disciplinary discussion among participants who rarely interact in conventional medical conferences.
• HealthQuake demonstrated the ability to attract globally recognized innovators and thought leaders despite modest organizational scale and resources.
• Many themes first discussed speculatively in 2017 — including AI-assisted diagnosis, home-centered digital care, bioartificial organs, precision medicine, and advanced tissue engineering — had already advanced significantly by the 2019 and 2022 meetings.
• The Summits established Detroit and DIREF as credible conveners of high-level discussion regarding the future of healthcare and medical technology.

The cumulative effect of the first three HealthQuake Summits has therefore been not only to identify emerging trends, but also to validate the Summit itself as a distinctive platform for anticipating and interpreting transformational change in healthcare.